Extended-spectrum β-lactamases in Enterobactetiaceae in Buenos Aires, Argentina, public hospitals

被引:136
|
作者
Quinteros, M [1 ]
Radice, M [1 ]
Gardella, N [1 ]
Rodriguez, MM [1 ]
Costa, N [1 ]
Korbenfeld, D [1 ]
Couto, E [1 ]
Gutkind, G [1 ]
机构
[1] Univ Buenos Aires, Argentina Fac Bioquim & Farm, Hosp Enfermedades Infecciosas FJ Muniz, RA-1113 Buenos Aires, DF, Argentina
关键词
D O I
10.1128/AAC.47.9.2864-2867.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Resistance to extended-spectrum cephalosporins is often associated with plasmid encoded extended spectrum beta-lactamases (ESBL). In order to evaluate the prevalence and diversity of ESBLs in enterobacteria in our city, a 1-month-period survey was carried out from April to May 2000. Extended-spectrum-cephalosporin-resistant strains, isolated from inpatient clinical specimens other than stools, were collected among 17 participating hospitals. From a total of 427 enterobacterial strains that were collected during this period, 39 were extended-spectrum cephalosporin resistant. The National Committee for Clinical Laboratory Standards' Screening and Confirmatory Tests for ESBL production were performed using cefotaxime and ceftazidime; cefepime and cefepime-clavulanic acid-containing disks were included. beta-Lactamases were characterized by isoelectric focusing and PCR amplification using specific primers. Three different ESBLs were detected: SHV-related (4 isolates), PER-2-type (9 isolates), and CTX-M-2-related (26 isolates). Sequencing of the corresponding genes confirmed CTX-M-2 in 19 of 21 and CTX-M-31 (an allelic variant) in the remaining 2 of 21. CTX-M-2 (or its variant) was detected in all Escherichia coli, Enterobacter aerogenes, Serratia marcescens, Proteus mirabilis, and Providencia stuartii strains, while PER-2 was detected in Enterobacter cloacae, E. aerogenes, and Klebsiella pneumoniae; SHV-related ESBL were found only in K. pneumoniae. These results clearly show that CTX-M-2 is the most prevalent ESBL produced by enterobacterial species isolated from public hospitals in Buenos Aires.
引用
收藏
页码:2864 / 2867
页数:4
相关论文
共 50 条
  • [31] Emerging extended-spectrum β-lactamases in Proteus mirabilis
    Pagani, L
    Migliavacca, R
    Pallecchi, L
    Matti, C
    Giacobone, E
    Amicosante, G
    Romero, E
    Rossolini, GM
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) : 1549 - 1552
  • [32] Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities
    Husna, Asmaul
    Rahman, Md. Masudur
    Badruzzaman, A. T. M.
    Sikder, Mahmudul Hasan
    Islam, Mohammad Rafiqul
    Rahman, Md. Tanvir
    Alam, Jahangir
    Ashour, Hossam M.
    BIOMEDICINES, 2023, 11 (11)
  • [33] Extended-spectrum β-lactamases:: structure and kinetic mechanism
    Page, M. G. P.
    CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 63 - 74
  • [34] Detection of extended-spectrum beta-lactamases
    Rao, P. N. S.
    Prasad, S. R.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2016, 34 (02) : 251 - 252
  • [35] Epidemiology of extended-spectrum β-lactamases in Sofia, Bulgaria
    Jacoby, GA
    Vacheva-Dobrevsky, R
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (06) : 385 - 388
  • [36] EXTENDED-SPECTRUM BETA-LACTAMASES OF ENTEROBACTERIACEAE
    MOLAND, ES
    THOMSON, KS
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (03) : 666 - 668
  • [37] GENETICS OF EXTENDED-SPECTRUM BETA-LACTAMASES
    JACOBY, GA
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 : 2 - 11
  • [38] Epidemiology of Extended-Spectrum β-Lactamases in Sofia, Bulgaria
    G. A. Jacoby
    R. Vacheva-Dobrevsky
    European Journal of Clinical Microbiology and Infectious Diseases , 2003, 22 : 385 - 388
  • [39] Evolution and clinical importance of extended-spectrum β-lactamases
    Rice, L
    CHEST, 2001, 119 (02) : 391S - 396S
  • [40] Extended-spectrum β-lactamases:: the role of inhibitors in therapy
    Amyes, SGB
    Miles, RS
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (04) : 415 - 417